Kiromic Biopharma, Inc. Quarterly Current Ratio in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Kiromic Biopharma, Inc. quarterly Current Ratio history and growth rate from Q2 2021 to Q3 2024.
  • Kiromic Biopharma, Inc. Current Ratio for the quarter ending September 30, 2024 was 26.9 %, a 17.7% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 26.9 +4.05 +17.7% Sep 30, 2024
Q2 2024 29.6 +10.5 +54.6% Jun 30, 2024
Q1 2024 27.2 -3.38 -11% Mar 31, 2024
Q4 2023 24.3 -58.7 -70.7% Dec 31, 2023
Q3 2023 22.8 -197 -89.6% Sep 30, 2023
Q2 2023 19.2 -569 -96.7% Jun 30, 2023
Q1 2023 30.6 -764 -96.1% Mar 31, 2023
Q4 2022 83 -838 -91% Dec 31, 2022
Q3 2022 219 -727 -76.8% Sep 30, 2022
Q2 2022 588 +243 +70.5% Jun 30, 2022
Q1 2022 795 Mar 31, 2022
Q4 2021 921 Dec 31, 2021
Q3 2021 946 Sep 30, 2021
Q2 2021 345 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.